查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2108371

基因組學市場分析及預測（至2035年）：按類型、產品、服務、技術、組件、應用、流程、最終用戶和解決方案分類

Genomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Process, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球基因組學市場預計將從2025年的359億美元成長到2035年的1,491億美元，複合年成長率（CAGR）為15.3%。精準醫療、大規模定序和基因組研究的日益普及是推動基因組學市場成長的主要因素。據美國國立衛生研究院（NIH）稱，「我們所有人」（All of Us）調查計畫發布了超過74.7萬名參與者的基因組和健康數據。其中包括超過53.5萬個全基因組序列和13億個基因變異，使其成為全球最大的整合基因組和電子健康記錄資料庫。大規模基因組資料集的日益普及正在加速生物標記的發現、疾病研究和個人化醫療的發展。

基因組學市場的「類型」細分包括功能基因組學、結構基因組學、比較基因組學和表觀基因。其中，功能基因體學憑藉其在闡明基因功能、生物路徑和疾病機制方面的廣泛應用，佔了較大的市場佔有率。結構基因組學支持基因組結構分析和遺傳變異識別，其重要性也日益凸顯。另一方面，比較基因體學能夠研究演化生物學和生物醫學研究中不同生物體之間的異同。表觀基因因其在理解基因表現調控、疾病進展和個人化治療策略方面的重要作用而正經歷快速成長。定序技術和生物資訊學的進步進一步推動了基因組學各個細分領域的創新。

市場區隔
類型 功能基因體學、結構基因體學、比較基因體學、表觀表觀基因及其他
產品 設備、耗材、試劑、軟體、試劑盒及其他物品。
服務 定序服務、生物資訊服務、基因型鑒定服務、基因編輯服務等。
科技 次世代定序、聚合酵素鏈鎖反應（PCR）、微陣列、CRISPR、桑格定序等。
成分 硬體、軟體、服務及其他
目的 診斷、藥物發現和開發、個人化醫療、農業和動物研究、法醫學等。
流程 樣品製備、定序、數據分析及其他服務。
最終用戶 研究中心、學術機構、製藥公司、生技公司、醫院和診所等。
解決方案 基因組資料管理、臨床基因體學、群體基因體學等。

基因組學市場的應用領域包括診斷、藥物發現與開發、個人化醫療、農業和動物研究以及法醫學。由於基因組檢測在疾病檢測、基因篩檢和生物標記識別方面的應用日益廣泛，診斷領域已成為主要應用領域。隨著基因組學被用於標靶識別、治療方案開發和精準藥物設計，藥物發現與開發領域也不斷擴展。個人化醫療正蓬勃發展，基因組分析提供的洞見能夠根據個體的基因譜制定個人化的治療方案。農業和動物研究以及法醫學領域也因基因組技術在育種、基因鑑定和生物分析方面的應用而不斷成長。

區域概覽

到2025年，北美將佔全球基因組學市場最大佔有率，這主要得益於其先進的基因組學研究基礎設施、強大的生物技術和製藥產業，以及對精準醫療的大量投資。該地區擁有眾多領先的基因組定序公司、研究機構和臨床實驗室，它們廣泛利用新一代定序（NGS）、基因表現分析和分子診斷技術進行疾病研究、藥物研發和個人化醫療。慷慨的政府資助、有利的監管支持，以及基因組學在腫瘤學、罕見疾病診斷和生殖醫學領域日益廣泛的應用，進一步加速了市場成長。此外，定序技術、生物資訊學和基因組數據分析的持續進步，也鞏固了北美在全球基因組學市場的領先地位。

在亞太地區，基因組學市場預計將迎來最高成長，這主要得益於生物技術研究的拓展、政府對基因組醫學投入的增加以及新一代定序技術的日益普及。中國、印度、日本、韓國和新加坡等國家正透過國家基因組舉措加強其基因組相關能力並擴展定序基礎設施，同時增加對精準醫療和人群定序計畫的投入。對疾病早期診斷、個人化醫療和基因檢測日益成長的需求，以及製藥和生物技術領域研究活動的不斷拓展，進一步推動了該地區的市場成長。此外，學術機構、醫療機構和生技公司之間合作的加強，以及醫療基礎設施的改善和政府的支持性政策，將使亞太地區在預測期內成為成長最快的區域市場。

主要趨勢和促進因素

人工智慧（AI）和多體學技術在基因組分析中的融合正在取得進展。

基因組學市場正呈現出強勁的趨勢，即整合人工智慧 (AI)、機器學習和多組體學技術，以提升基因組數據的解讀能力並加速生物學發現。先進的計算平台使研究人員和醫療專業人員能夠分析大規模定序資料集，識別與疾病相關的基因變異，並制定個人化的治療策略。基因組學與轉錄組學、蛋白質組學和代謝體學的結合，正在加深我們對複雜疾病的理解，並推動精準醫療的發展。此外，新一代定序 (NGS)、全基因組定序和基於雲端的基因組學平台的進步，正在提升研究、診斷和臨床應用的可及性、可擴展性和效率。

精準醫療的廣泛應用和定序成本的降低

精準醫療的日益普及和基因組定序成本的持續下降是基因組學市場的主要驅動力。價格合理且先進的定序技術使得基因組檢測在疾病診斷、藥物研發、人群健康調查和個人化醫療等領域更廣泛的應用。癌症、罕見遺傳疾病和慢性病的日益增多，推動了對基因組診斷和標靶治療方法的需求。此外，製藥和生物技術公司正在利用基因組資訊進行生物標記發現、最佳化臨床試驗和開發療法。政府主導的舉措的擴展、醫療保健領域投資的增加以及測序基礎設施的日益完善，都在進一步加速全球市場的成長。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 功能基因體學
    • 結構基因體學
    • 比較基因組學
    • 表觀基因
    • 其他
  • 市場規模及預測：依產品分類
    • 裝置
    • 消耗品
    • 試劑
    • 軟體
    • 成套工具
    • 其他
  • 市場規模及預測：依服務分類
    • 定序服務
    • 生物資訊服務
    • 基因型鑒定服務
    • 基因編輯服務
    • 其他
  • 市場規模及預測：依技術分類
    • 下一代定序
    • 聚合酵素鏈鎖反應
    • 微陣列
    • CRISPR
    • 桑格定序
    • 其他
  • 市場規模及預測：依應用領域分類
    • 診斷
    • 藥物發現和藥物開發
    • 個人化醫療
    • 農業/動物研究
    • 法醫學
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 研究中心
    • 學術機構
    • 製藥公司
    • 生技公司
    • 醫院和診所
    • 其他
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
    • 其他
  • 市場規模及預測：依製程分類
    • 樣品製備
    • 順序
    • 數據分析
    • 其他
  • 市場規模及預測：按解決方案分類
    • 基因組資料管理
    • 臨床基因組學
    • 群體基因組學
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 定價和成本利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • Agilent Technologies
  • Roche
  • Bio-Rad Laboratories
  • Becton Dickinson
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • PerkinElmer
  • Danaher
  • 10x Genomics
  • Genomic Health
  • Myriad Genetics
  • Twist Bioscience
  • Ginkgo Bioworks
  • Personalis
  • SomaLogic
  • Adaptive BIoTechnologies
  • Fulgent Genetics

第9章 關於我們

簡介目錄
Product Code: GIS20110

The global Genomics Market is projected to grow from $35.9 billion in 2025 to $149.1 billion by 2035, at a compound annual growth rate (CAGR) of 15.3%. The genomics market is driven by the increasing adoption of precision medicine, large-scale sequencing initiatives, and genomic research. According to the National Institutes of Health (NIH), the All of Us Research Program released genomic and health data from more than 747,000 participants, including over 535,000 whole-genome sequences and 1.3 billion genetic variants, making it the world's largest integrated genomics and electronic health record database. The growing availability of large-scale genomic datasets is accelerating biomarker discovery, disease research, and personalized medicine.

The Type segment of the Genomics Market includes functional genomics, structural genomics, comparative genomics, epigenomics, and others. Among these, functional genomics holds a significant market share due to its increasing use in understanding gene functions, biological pathways, and disease mechanisms. Structural genomics is gaining importance as it supports the analysis of genome structures and identification of genetic variations, while comparative genomics enables researchers to study similarities and differences among organisms for evolutionary and biomedical research. Epigenomics is witnessing rapid growth due to its role in understanding gene regulation, disease progression, and personalized treatment strategies. Advancements in sequencing technologies and bioinformatics are further driving innovation across genomics segments.

Market Segmentation
TypeFunctional Genomics, Structural Genomics, Comparative Genomics, Epigenomics, Others
ProductInstruments, Consumables, Reagents, Software, Kits, Others
ServicesSequencing Services, Bioinformatics Services, Genotyping Services, Gene Editing Services, Others
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Microarray, CRISPR, Sanger Sequencing, Others
ComponentHardware, Software, Services, Others
ApplicationDiagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Forensics, Others
ProcessSample Preparation, Sequencing, Data Analysis, Others
End UserResearch Centers, Academic Institutions, Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics, Others
SolutionsGenomic Data Management, Clinical Genomics, Population Genomics, Others

The Application segment of the Genomics Market includes diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, forensics, and others. Diagnostics represent a major application area due to the increasing adoption of genomic testing for disease detection, genetic screening, and biomarker identification. Drug discovery and development are expanding with the use of genomics for target identification, therapeutic development, and precision drug design. Personalized medicine is gaining momentum as genomic insights enable customized treatment approaches based on individual genetic profiles. Agriculture and animal research, along with forensic applications, are also growing due to the use of genomic technologies for breeding improvement, genetic identification, and biological analysis.

Geographical Overview

North America held the largest share of the global genomics market in 2025, driven by its advanced genomics research infrastructure, strong biotechnology and pharmaceutical industries, and substantial investments in precision medicine. The region is home to leading genomic sequencing companies, research institutions, and clinical laboratories that extensively utilize next-generation sequencing (NGS), gene expression analysis, and molecular diagnostics for disease research, drug discovery, and personalized healthcare. Robust government funding, favorable regulatory support, and increasing adoption of genomics in oncology, rare disease diagnosis, and reproductive health have further accelerated market growth. Additionally, continuous advancements in sequencing technologies, bioinformatics, and genomic data analytics reinforce North America's leadership in the global genomics market.

Asia Pacific is expected to witness the highest growth in the genomics market owing to expanding biotechnology research, increasing government investments in genomic medicine, and rising adoption of next-generation sequencing technologies. Countries such as China, India, Japan, South Korea, and Singapore are strengthening their genomics capabilities through national genome initiatives, expanding sequencing infrastructure, and increasing investments in precision medicine and population genomics projects. Growing demand for early disease diagnosis, personalized therapies, and genetic testing, along with expanding pharmaceutical and biotechnology research activities, is further driving regional market growth. Moreover, increasing collaborations between academic institutions, healthcare organizations, and biotechnology companies, coupled with improving healthcare infrastructure and supportive government policies, are expected to position Asia Pacific as the fastest-growing regional market during the forecast period.

Key Trends and Drivers

Increasing Integration of Artificial Intelligence and Multi-Omics in Genomic Analysis:

The Genomics Market is witnessing a strong trend toward the integration of artificial intelligence (AI), machine learning, and multi-omics approaches to improve genomic data interpretation and accelerate biological discoveries. Advanced computational platforms are enabling researchers and healthcare providers to analyze large-scale sequencing datasets, identify disease-associated genetic variants, and develop personalized treatment strategies. The combination of genomics with transcriptomics, proteomics, and metabolomics is enhancing understanding of complex diseases and supporting precision medicine initiatives. Additionally, advancements in next-generation sequencing (NGS), whole-genome sequencing, and cloud-based genomic platforms are improving accessibility, scalability, and efficiency across research, diagnostics, and clinical applications.

Rising Adoption of Precision Medicine and Declining Sequencing Costs:

The increasing adoption of precision medicine and the continuous reduction in genomic sequencing costs are major drivers of the Genomics Market. Affordable and advanced sequencing technologies have enabled broader use of genomic testing in disease diagnosis, drug development, population health studies, and personalized therapies. The growing prevalence of cancer, rare genetic disorders, and chronic diseases is increasing demand for genomic-based diagnostics and targeted treatment approaches. Furthermore, pharmaceutical and biotechnology companies are leveraging genomic insights for biomarker discovery, clinical trial optimization, and therapeutic development. Expanding government-funded genome initiatives, increasing healthcare investments, and growing availability of sequencing infrastructure are further accelerating global market growth.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Functional Genomics
    • 4.1.2 Structural Genomics
    • 4.1.3 Comparative Genomics
    • 4.1.4 Epigenomics
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Consumables
    • 4.2.3 Reagents
    • 4.2.4 Software
    • 4.2.5 Kits
    • 4.2.6 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sequencing Services
    • 4.3.2 Bioinformatics Services
    • 4.3.3 Genotyping Services
    • 4.3.4 Gene Editing Services
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Polymerase Chain Reaction
    • 4.4.3 Microarray
    • 4.4.4 CRISPR
    • 4.4.5 Sanger Sequencing
    • 4.4.6 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Diagnostics
    • 4.5.2 Drug Discovery and Development
    • 4.5.3 Personalized Medicine
    • 4.5.4 Agriculture and Animal Research
    • 4.5.5 Forensics
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Research Centers
    • 4.6.2 Academic Institutions
    • 4.6.3 Pharmaceutical Companies
    • 4.6.4 Biotechnology Companies
    • 4.6.5 Hospitals and Clinics
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Preparation
    • 4.8.2 Sequencing
    • 4.8.3 Data Analysis
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Genomic Data Management
    • 4.9.2 Clinical Genomics
    • 4.9.3 Population Genomics
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Qiagen
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilent Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Roche
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bio-Rad Laboratories
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Becton Dickinson
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Pacific Biosciences
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Oxford Nanopore Technologies
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 PerkinElmer
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Danaher
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 10x Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Genomic Health
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Myriad Genetics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Twist Bioscience
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Ginkgo Bioworks
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Personalis
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 SomaLogic
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Adaptive Biotechnologies
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Fulgent Genetics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us